Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Account Payables (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Change in Account Payables for 2 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 11390.0% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Dec 2025, up 402.17% year-over-year, with the annual reading at $6.0 million for FY2025, 402.17% up from the prior year.
  • Change in Account Payables for Q4 2025 was $1.1 million at Pyxis Oncology, up from $344000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $6.6 million in Q2 2025, with the low at -$2.0 million in Q1 2025.